Merck’s COVID pill shows lower efficacy in updated study

Drugmaker says final analysis of trial results showed molnupiravir showed 30 percent risk reduction.

from Al Jazeera – Breaking News, World News and Video from Al Jazeera https://ift.tt/30Xh1EM